Biology subjects

Tollemeto, M.

Publications and source records attributed to Tollemeto, M..

4 recordsLinked to original sources

bioRxiv2026

Layer-by-Layer Polymeric Films: A Novel Approach to Buccal GLP-1 Delivery

Buccal delivery offers a promising alternative to oral drug administration by enabling direct systemic absorption and avoiding first-pass metabolism. Multilayer polymeric films represent a promising strategy for the sequential delivery of drug and absorption enhancer in the oral cavity. Here, dual- and triple-layer films were fabricated via slot-die coating, incorporating a GLP-1 receptor agonist (GLP-1-RA) and the penetration enhancer sodium glycodeoxycholate (GDC). These were co-loaded in dual-layer films or compartmentalized in triple-layer films. Scanning electron microscopy and optical coherence tomography confirmed well-defined, distinct layers with thicknesses suitable for buccal administration (339 {+/-} 10.24 {micro}m and 487 {+/-} 36.5 {micro}m for dual- and triple-layer films, respectively). Both designs exhibited good mucoadhesion and mucosal compatibility, and preserved the secondary structure of GLP-1-RA. In vitro release studies showed rapid diffusion of GDC and GLP-1-RA from dual-layer films, whereas triple-layer films enabled sustained, sequential release of GDC and GLP-1-RA. Ex vivo porcine buccal mucosa studies showed higher GLP-1-RA and GDC flux from triple-layer films compared to dual-layer films. The films also did not compromise epithelial integrity, in contrast to the direct application of GLP-1-RA and GDC, which caused significant epithelial disruption. These results demonstrate that multilayer film architecture and spatial layering can be harnessed to control release kinetics, maximize peptide penetration, and minimize tissue stress, offering a versatile platform for safe and effective peptide delivery. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=93 SRC="FIGDIR/small/700335v1_ufig1.gif" ALT="Figure 1"> View larger version (25K): org.highwire.dtl.DTLVardef@76858borg.highwire.dtl.DTLVardef@1397e74org.highwire.dtl.DTLVardef@19d1841org.highwire.dtl.DTLVardef@a369c5_HPS_FORMAT_FIGEXP M_FIG C_FIG

bioengineering↗

bioRxiv2025

Enzyme-powered DNA origami nanostructures for enhanced mucosal diffusion

Crossing mucosal barriers is a central challenge for oral drug delivery, where nanoparticle design must balance stability with mobility in complex fluids. Here, we demonstrate DNA origami as a programmable platform to investigate these processes. Using FRET analysis, we show that DNA nanostructures retain their structural integrity for extended periods in porcine intestinal fluid and mucus, establishing their suitability for biologically relevant environments. Building on this, we used single-particle tracking to assess enzyme-powered propulsion within mucus. Both urease and catalase enhanced diffusion only when anchored to the DNA origami structure, with propulsion persisting for tens of minutes. Importantly, enzyme spatial organization dictated performance: symmetric urease placement improved mobility via uniform local pH shifts, while asymmetric catalase placement enabled efficient bubble-driven propulsion. These results highlight DNA origami as a uniquely versatile tool to dissect structure-function relationships in mucus transport and provide design principles for next-generation, enzyme-powered oral delivery systems.

bioengineering↗

bioRxiv2025

Predicting DNA origami stability in physiological media by machine learning

DNA origami nanostructures offer substantial potential as programmable, biocompatible platforms for drug delivery and diagnostics. However, their structural stability under physiological conditions remains a major barrier to practical applications. Stability assessment of DNA origami nanostructures has traditionally relied on image-based and empirical approaches, which are time-consuming and difficult to generalize across conditions. To address these limitations, we developed a machine learning approach for DNA origami stability prediction, based on measurable physicochemical parameters. Using dynamic light scattering (DLS) to quantify diffusion coefficients as a proxy for structural integrity, we characterized over 1400 DNA origami samples under varying physiologically relevant variables: temperature, incubation time, MgCl2 concentration, pH, and DNase I concentrations. The predictive performance of the model was confirmed using an independent set of samples under previously untested conditions. This data-driven approach offers a scalable and generalizable framework to guide the design of robust DNA nanostructures for biomedical applications.

bioengineering↗

bioRxiv2025

Topology Determines DNA Origami Diffusion in Intestinal Mucus

Efficient nanomedicine delivery across mucosal barriers remains a challenge, due to the complex and poorly understood relationship between nanoparticle design and mucus transport. Here, we present DNA origami as a platform to investigate how nanoparticle shape and ligand patterning influence diffusivity in mucus. By decoupling these parameters while maintaining identical material composition, we systematically evaluated the diffusion of rod, icosahedral, and rectangular nanostructures using high-resolution single-particle tracking. Our results reveal that diffusivity in mucus is not solely determined by shape or functionalization alone, but by their interplay: while unmodified rods diffused poorly, their mobility increased significantly upon antibody functionalization, reaching a maximum at an intermediate ligand density. In contrast, rods and icosahedra exhibited less pronounced and non-optimal responses to surface modification. These findings highlight the importance of topology-specific optimization in nanoparticle design and demonstrate the utility of DNA nanotechnology to uncover design rules for next generation mucus-penetrating drug delivery systems.

bioengineering↗